Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Jan 25, 2023 8:00 am EST

IceCure's ProSense Presented in Hands-On Training Course at The American Society of Breast Surgeons Breast Follows Ultrasound Course

Jan 23, 2023 8:00 am EST

U.S. Patent Office Grants Notice of Allowance to IceCure for Novel Cryogenic Pump for Next-Generation Cryoablation Systems

Jan 18, 2023 8:00 am EST

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems

Jan 04, 2023 8:00 am EST

IceCure Medical CEO Issues Letter to Shareholders

Dec 23, 2022 4:00 pm EST

IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Dec 21, 2022 9:00 am EST

IceCure Medical Ltd. Announces Pricing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Dec 20, 2022 4:00 pm EST

IceCure Medical Ltd. Announces Proposed Public Offering

Dec 19, 2022 4:05 pm EST

IceCure's ProSense Safe and Effective in Treating Kidney Tumors with 89.5% Recurrence-Free Rate Based on Interim Study Results

Dec 06, 2022 8:00 am EST

IceCure Appoints Vincent Chun Hung Chan to Serve as an Independent Director on its Board of Directors

Dec 05, 2022 7:00 am EST

IceCure Medical Reports Financial Results for the Nine Months Ended September 30, 2022 and Provides Update on Recent Operational Highlights

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2025 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023